Stefanie S. Schalm
Stefanie S. Schalm publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer and Cancer Genomics and Diagnostics.
- World rank
- #589,688 of 7,710,434 ranked researchers
- Rank in United States
- #202,681 of 1,627,098
- Works
- 61
- Citations
- 5.4k
- Citations per work
- 89.0
What does Stefanie S. Schalm research?
Stefanie S. Schalm's work is mostly in Biochemistry, Genetics and Molecular Biology (45%), Medicine (31%), Neuroscience (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2948.0%
- Health Sciences1931.0%
- Medicine1931.0%
- Everything else1321.0%
- 1Molecular Biology35% of their works
- 2Oncology16% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Cancer Research10% of their works
- 5Hematology5% of their works
- 6Cellular and Molecular Neuroscience3% of their works
Research topics
Which keywords describe Stefanie S. Schalm's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Prognostic Factors, ALK Inhibitors, Chemotherapy, EGFR Mutations, mTOR and Signaling.
- Topoisomerases
- Protein Kinases
- Small-Cell Lung Cancer
- Acute Myeloid Leukemia
- Histone Modification
- Mutational Signatures
- mTOR
- EGFR Mutations
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Prognostic Factors
- Chemotherapy
- Signaling
- Cancer Genomics
- DNA Methylation
- AML
- Genomic Profiles
- DNA
- Ras Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Targeted Therapy213 topics
- Clinical Trials142 topics
- Prognostic Factors102 topics
- ALK Inhibitors91 topic
- Chemotherapy92 topics
- EGFR Mutations91 topic
- Signaling81 topic
- mTOR81 topic
- Cancer Genomics71 topic
- Mutational Signatures71 topic
- DNA Methylation61 topic
- Histone Modification61 topic
- AML51 topic
- Acute Myeloid Leukemia51 topic
- Genomic Profiles51 topic
- Small-Cell Lung Cancer51 topic
- DNA41 topic
- Protein Kinases41 topic
- Ras Signaling41 topic
- Topoisomerases41 topic
Where does Stefanie S. Schalm work?
Stefanie S. Schalm's main affiliation in the publication record is Blueprint Medicines (United States), United States.
How many publications and citations does Stefanie S. Schalm have?
OpenAlex counts 61 works and 5,428 citations for Stefanie S. Schalm, an h-index of 18, ranking #589,688 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stefanie S. Schalm. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.